Table 1
Baseline characteristics, angiographic findings, procedural characteristics, and post procedure complications stratified by discharge time.
| Characteristics | Total | Discharge after Primary PCI | P-value | |
|---|---|---|---|---|
| Very Early(≤ 24 hours) | Early(24 to 48 hours) | |||
| Total (N) | 600 | 504 | 96 | – |
| Gender | ||||
| Male | 81.8% (491) | 83.1% (419) | 75% (72) | 0.058 |
| Female | 18.2% (109) | 16.9% (85) | 25% (24) | |
| Age (years) | 54.89 ± 11.08 | 54.63 ± 10.84 | 56.23 ± 12.23 | 0.195 |
| ≤ 45 years | 21% (126) | 21.2% (107) | 19.8% (19) | 0.230 |
| 46 to 65 years | 63% (378) | 63.9% (322) | 58.3% (56) | |
| > 65 years | 16% (96) | 14.9% (75) | 21.9% (21) | |
| Killip class | ||||
| I | 90% (540) | 91.5% (461) | 82.3% (79) | 0.006* |
| II | 10% (60) | 8.5% (43) | 17.7% (17) | |
| Duration of CP (minutes) | 270 [150–450] | 270 [150–448] | 300 [145–570] | 0.311 |
| Type of myocardial infarction | ||||
| Anterior | 51.8% (311) | 53% (267) | 45.8% (44) | 0.435 |
| Inferior | 41.5% (249) | 40.5% (204) | 46.9% (45) | |
| Posterior | 4.7% (28) | 4.4% (22) | 6.3% (6) | |
| Lateral | 2% (12) | 2.2% (11) | 1% (1) | |
| Co-morbid conditions | ||||
| Hypertension | 52.5% (315) | 50.4% (254) | 63.5% (61) | 0.018* |
| Diabetes | 37.2% (223) | 36.7% (185) | 39.6% (38) | 0.593 |
| Family history of CAD | 4.5% (27) | 4.6% (23) | 4.2% (4) | 0.864 |
| Smoking | 32.7% (196) | 34.3% (173) | 24% (23) | 0.047* |
| Obesity | 4.3% (26) | 4.6% (23) | 3.1% (3) | 0.526 |
| Access for the procedure | ||||
| Radial | 47.5% (285) | 50% (252) | 34.4% (33) | 0.005* |
| Femoral | 52.5% (315) | 50% (252) | 65.6% (63) | |
| Number of vessels involved | ||||
| Single vessel disease | 22.8% (137) | 23.6% (119) | 18.8% (18) | 0.066 |
| Two vessels disease | 36.8% (221) | 38.1% (192) | 30.2% (29) | |
| Three vessels disease | 40.3% (242) | 38.3% (193) | 51% (49) | |
| Culprit coronary artery | ||||
| Left main | 1.7% (10) | 1.8% (9) | 1% (1) | 0.513 |
| LAD | 55.7% (334) | 56.9% (287) | 49% (47) | |
| RCA | 29.5% (177) | 28% (141) | 37.5% (36) | |
| LCX | 11.5% (69) | 11.5% (58) | 11.5% (11) | |
| Ramus | 1.2% (7) | 1.2% (6) | 1% (1) | |
| Diagonal | 0.5% (3) | 0.6% (3) | 0% (0) | |
| TIMI (pre-procedure) flow grade | ||||
| 0 | 52.2% (313) | 49.4% (249) | 66.7% (64) | 0.010* |
| I | 40.7% (244) | 42.5% (214) | 31.3% (30) | |
| II | 4.5% (27) | 5.2% (26) | 1% (1) | |
| III | 2.7% (16) | 3% (15) | 1% (1) | |
| TIMI (post-procedure) flow grade | ||||
| 0 | 1% (6) | 1% (5) | 1.1% (1) | <0.001* |
| I | 0.5% (3) | 0.2% (1) | 2.1% (2) | |
| II | 17.5% (103) | 14.3% (71) | 34% (32) | |
| III | 81% (477) | 84.4% (418) | 62.8% (59) | |
| Complication(s)/outcomes | ||||
| Total | 2% (12) | 0.8% (4) | 8.3% (8) | <0.001* |
| Contrast-induced nephropathy (CIN) | 16.7% (2) | 0% (0) | 25% (2) | 0.001* |
| Major bleeding | 16.7% (2) | 25% (1) | 12.5% (1) | 0.189 |
| Ventricular tachycardia | 16.7% (2) | 25% (1) | 12.5% (1) | 0.189 |
| Cardiac arrest | 16.7% (2) | 0% (0) | 25% (2) | 0.001* |
| Dissection | 16.7% (2) | 25% (1) | 12.5% (1) | 0.189 |
| Others | 16.7% (2) | 25% (1) | 12.5% (1) | 0.189 |
[i] * Significant at 5%.
PCI = percutaneous coronary intervention; CP = chest pain; CAD = coronary artery diseases; LAD = left anterior descending artery; RCA = right coronary artery; LCX = left circumflex artery; TIMI = thrombolysis in myocardial infarction.
Table 2
Post-procedure 7-day and 30-day follow-up outcomes stratified by discharge time.
| Outcomes | Total | Discharge after Primary PCI | P-value | |
|---|---|---|---|---|
| Very Early (≤ 24 hours) | Early (24 to 48 hours) | |||
| Total (N) | 600 | 504 | 96 | – |
| Outcomes after 7-days | ||||
| Loss to follow-up | 4% (24) | 3% (15) | 9.4% (9) | – |
| Total (N) at 7-day follow-up | 576 | 489 | 87 | – |
| MACE | 3.5% (20) | 3.7% (18) | 2.3% (2) | 0.516 |
| All-cause death | 1.4% (8) | 1.6% (8) | 0% (0) | 0.230 |
| Myocardial infarction | 0.3% (2) | 0.4% (2) | 0% (0) | 0.550 |
| Bleeding events | 0.5% (3) | 0.6% (3) | 0% (0) | 0.464 |
| Cerebrovascular events | 0.9% (5) | 0.8% (4) | 1.1% (1) | 0.759 |
| Hospitalization for unstable angina | 0.5% (3) | 0.4% (2) | 1.1% (1) | 0.377 |
| Unplanned coronary revascularization | 0.9% (5) | 1% (5) | 0% (0) | 0.343 |
| Outcomes after 30 days | ||||
| Loss to follow-up | 4.3% (26) | 3.4% (17) | 9.4% (9) | – |
| Total (N) at 30-day follow-up | 574 | 487 | 87 | – |
| MACE | 4.9% (28) | 5.1% (25) | 3.4% (3) | 0.501 |
| All-cause death | 2.3% (13) | 2.5% (12) | 1.1% (1) | 0.448 |
| Myocardial infarction | 0.5% (3) | 0.6% (3) | 0% (0) | 0.463 |
| Bleeding events | 0.5% (3) | 0.6% (3) | 0% (0) | 0.463 |
| Cerebrovascular events | 1.4% (8) | 1.4% (7) | 1.1% (1) | 0.833 |
| Hospitalization for unstable angina | 0.5% (3) | 0.4% (2) | 1.1% (1) | 0.379 |
| Unplanned coronary revascularization | 1.2% (7) | 1.4% (7) | 0% (0) | 0.261 |
[i] * Significant at 5%.
PCI = percutaneous coronary intervention; MACE = major adverse cardiac event.
Table 3
Post-procedure 7-day and 30-day follow-up outcomes stratified by Zwolle risk score (ZRS).
| Outcomes | Total | Zwolle risk score (ZRS) | p-value | |
|---|---|---|---|---|
| Low-risk (≤ 3) | High-risk (≥ 4) | |||
| Total (N) | 600 | 491 | 109 | – |
| Outcomes after 7-days | ||||
| Loss to follow-up | 4% (24) | 3.9% (19) | 4.6% (5) | – |
| Total (N) at 7-day follow-up | 576 | 472 | 104 | – |
| MACE | 3.5% (20) | 3.6% (17) | 2.9% (3) | 0.718 |
| All-cause death | 1.4% (8) | 1.5% (7) | 1% (1) | 0.681 |
| Myocardial infarction | 0.3% (2) | 0.4% (2) | 0% (0) | 0.506 |
| Bleeding events | 0.5% (3) | 0.6% (3) | 0% (0) | 0.415 |
| Cerebrovascular events | 0.9% (5) | 0.8% (4) | 1% (1) | 0.910 |
| Hospitalization for unstable angina | 0.5% (3) | 0.6% (3) | 0% (0) | 0.415 |
| Unplanned coronary revascularization | 0.9% (5) | 0.8% (4) | 1% (1) | 0.910 |
| Outcomes after 30 days | ||||
| Loss to follow-up | 4.3% (26) | 4.3% (21) | 4.6% (5) | – |
| Total (N) at 30-day follow-up | 574 | 470 | 104 | – |
| MACE | 4.9% (28) | 4.7% (22) | 5.8% (6) | 0.641 |
| All-cause death | 2.3% (13) | 1.9% (9) | 3.8% (4) | 0.231 |
| Myocardial infarction | 0.5% (3) | 0.4% (2) | 1% (1) | 0.493 |
| Bleeding events | 0.3% (2) | 0.4% (2) | 0% (0) | 0.505 |
| Cerebrovascular events | 1.4% (8) | 1.5% (7) | 1% (1) | 0.678 |
| Hospitalization for unstable angina | 0.5% (3) | 0.6% (3) | 0% (0) | 0.414 |
| Unplanned coronary revascularization | 1.2% (7) | 1.3% (6) | 1% (1) | 0.791 |
[i] MACE = major adverse cardiac event.
